Stabilized pemetrexed formulation
US9265832B2 · kind B2 · utility
3Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2013 |
| Grant date | Feb 23, 2016 |
| Priority date | — |
| Expiry date | Nov 29, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a stabilized pemetrexed formulation, and more particularly to a stabilized pemetrexed formulation comprising acetylcysteine as antioxidant and a citrate salt as buffer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.